Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01669434 · ClinicalTrials.gov registry record · Phase 4
Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery
A Phase 4 study of Hypotension on Induction, sponsored by University of Nebraska.
- Completed
- Registry status
- Phase 4
- Development phase
- 291
- Enrollment target
- 1
- Study location
NCT01669434 is a Phase 4 study of Hypotension on Induction that has completed, run by University of Nebraska. The registered enrollment target is 291 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01669434, a Phase 4 study of Hypotension on Induction, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 291 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary research hypothesis: Patients who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #1: Patients who continue their chronic ACEI up to and including the morning of a non-cardiac, non-vascular surgery will experience better postoperative control of hypertension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #2: Patients who continue their chronic ACEI up to and including the morning of a non-cardiac, non-vascular surgery will experience less acute renal failure than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #3: In the subgroup of patients with a preoperative systolic blood pressure less than 110 mmHg, those who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #4: In the subgroup of patients above the age of 64, those who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively.
Conditions Studied
Interventions
- DRUG ACEI continuation
- DRUG ACEI omission
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 291 participants |
| Start Date | 2015-06-01 |
| Est. Completion | 2016-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01669434
The ClinicalTrials.gov registry entry for NCT01669434 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 291 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypotension on Induction appearing as the primary indexed condition, and to 2 interventions - of which ACEI continuation is the first listed.
NCT01669434 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT01669434 about?
NCT01669434 is a clinical study titled "Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery". Primary research hypothesis: Patients who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #1: P...
What is the current status of trial NCT01669434?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 291 participants. The study started on 2015-06-01. Estimated completion is 2016-12-01.
What conditions does trial NCT01669434 study?
This clinical trial studies the following conditions: Hypotension on Induction.
What interventions are being tested in trial NCT01669434?
The interventions under investigation include: ACEI continuation (DRUG), ACEI omission (DRUG).
Who is sponsoring clinical trial NCT01669434?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01669434 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.